Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 2,432 shares at $45.00 ($109K) on 2025-07-30, disclosed to the SEC on 2025-08-01.
Scheduled sale ($109k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-03-11 | $24.2M | — | Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |